The tolerability profile of terbinafine

Reviews in Contemporary Pharmacotherapy

Volumn 8, Issue 5, 1997, Pages 373-386

  Suhonen, Raimo ^a   Neuvonen, Pertti J ^a  

^a MIKKELI CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; LIVER ENZYME; PYRROLE; TERBINAFINE;

ABDOMINAL PAIN; ARTICLE; CLINICAL TRIAL; CONSTIPATION; DIARRHEA; DRUG METABOLISM; DRUG SAFETY; DRUG TOLERABILITY; DYSPEPSIA; ECZEMA; GASTROINTESTINAL SYMPTOM; HEADACHE; HEART RATE VARIABILITY; HEARTBURN; HUMAN; MAJOR CLINICAL STUDY; MALE SEXUAL DYSFUNCTION; META ANALYSIS; NAUSEA; PRURITUS; RASH; TASTE DISORDER; URTICARIA; XEROSTOMIA;

EID: 0030712187     PISSN: 09548602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Ahonen J, Olkkola KT, Neuvonen PJ. Effect of itraconazole and terbinafine on the pharmacokinetics and pharmacodynamics of midazolam in healthy volunteers. Br J Clin Pharmacol 1995; 40: 270-272.
2. Anon. Terbinafine. First report of hepatitis?: case report. Reactions Annual, 1993: 321.
3. Anon. Terbinafine. Hyperglycaemia?: 3 case reports. Reactions, 28 May, 1994a: 1.
4. Anon. Terbinafine - hematological disorders. Can Med Assoc J 1994b; 151: 64 and 68.
5. Anon. Reports from CARM. Reactions, 1 July 1995: 3.
6. Anon. Hepatobiliary reactions with terbinafine hydrochloride. Can Med Assoc J 1996; 154: 62-63.
7. Arenas R, Dominquez-Cherit J, Fernandez LM. Open randomized comparison of itraconazole versus terbinafine in onychomycosis. Int J Dermatol 1995; 34: 138-143.
8. Aste N, Pau M, Pinna AL, Colombo MD, Biggio P. Clinical efficacy and tolerability of terbinafine in patients with pityriasis versicolor. Mycoses 1991; 34: 353-357.
9. Back DJ, Tjia JF. Azoles and allylamines: the clinical implications of interaction with cytochrome P-450 enzymes. J Dermatol Treat 1990; 1: 11-13.
10. Back DJ, Tjia JF. Comparative effects of the antimycotic drugs ketoconazole, fluoconazole, itraconazole and terbinafine on the metabolism of cyclosporin by human liver microsomes. Br J Clin Pharmacol 1991; 32: 624-626.
11. Back DJ, Stevenson P, Tjia JF. Comparative effects of two antimycotic agents, ketoconazole and terbinafine, on the metabolism of tolbutamide, ethinylestradiol, cyclosporin and ethoxycoumarin by human liver microsomes in vitro. Br J Clin Pharmacol 1989; 28: 166-170.
12. Back DJ, Tjia JF, Abel SM. Azoles, allylamines and drug metabolism. Br J Dermatol 1992; 126: 14-18.
13. Balfour JA, Faulds D. Terbinafine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial mycoses. Drugs 1992; 43: 259-284.
14. Baudraz-Rosselet F, Rakosi J, Will PB, Kenzelmann R. Treatment of onychomycosis with terbinafine. Br J Dermatol 1992; 126 (Suppl 39): 40-46.
15. Beutler M, Hartmann K, Kuhn M, Gartmann J. Taste disorders and terbinafine. Br Med J 1993; 307: 26.
16. Bickers DR. Antifungal therapy: potential interactions with other classes of drugs. J Am Acad Dermatol 1994; 31: S87-S90.
17. Birnbaum JE. Pharmacology of the allylamines. J Am Acad Dermatol 1990; 23: 782-785.
18. Bräutigam M, Nolting S, Schopf RE, Weidinger G, for the Seventh Lamisil German Onychomycosis Study Group. German randomised double blind multicentre comparison of terbinafine and itraconazole for treatment of toenail tinea infection. Br J Dermatol 1996; 134 (Suppl 46): 18-21.
19. Brodell RT, Elewski BE. Systemic antifungal drugs and drug interactions. J Am Acad Dermatol 1995; 33: 259-260.
20. Buchwald J, Hoffman J, Kejda J, Kuklova I, Nogova D, Richterova M. Terbinafine in the treatment of dermatophyte onychomycosis. Abstract. Presented at the International Summit on Cutaneous Antifungal Therapy, Vancouver, Canada, May 26-28, 1996.
21. Budimulja U, Kuswadji K, Bramono S et al. A double-blind, randomized, stratified controlled study of the treatment of tinea imbricata with oral terbinafine and itraconazole. Br J Dermatol 1994; 130 (Suppl 43): 29-31.
22. Carstens J, Wendelboe P, Sogaard H, Thestrup-Pedersen K. Toxic epidermal necrolysis and erythema multiforme following therapy with terbinafine. Acta Derm Venereol 1994; 74: 391-392.
23. Cole GW, Stricklin G. A comparison of a new antifungal, terbinafine with griseofulvin as therapy for tinea corporis. Arch Dermatol 1989; 125: 1537-1539.
24. Cramer JA, Robbins BA, Gareffa S et al. Pharmacokinetic effects of single-dose terbinafine and single-dose sustained-release nifedipine co-administration in healthy volunteers. Data on file. East Hanover, NJ: Novartis Pharma Inc., 1996.
25. De Backer M, De Keyser P, De Vroey C, Lesaffre E. 12 week treatment for dermatophyte toe onychomycosis: terbinafine 250 mg/day vs itraconazole 200 mg/day - a double blind comparative trial. Br J Dermatol 1996; 134 (Suppl 46): 16-17.
26. De Keyser P, De Backer M, Massart DL, Westelinck KJ. Two-week oral treatment of tinea pedis, comparing terbinafine (250 mg/day) with itraconazole (100 mg/day): a double-blind, multicentre study. Br J Dermatol 1994; 130 (Suppl 43): 22-25.